Vanda Pharmaceuticals DPO Ratio 2011-2026 | VNDA

Annual DPO Ratio Vanda Pharmaceuticals

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008
-	-	-	-	-	-	-	-	416	239	245	193	-	812	-	-	-	-

All numbers in USD currency

Maximum	Minimum	Average
812	193	381

Issuer	DPO Ratio	Price	% 24h	Market Cap	Country
Happiness Biotech Group Limited HAPP	5.06 K	-	1.35 %	$ 17.8 M	China
Dynavax Technologies Corporation DVAX	52.8	-	-	$ 2.02 B	USA
AgeX Therapeutics AGE	5.24 K	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	2.24 K	-	-	$ 866 M	China
Deciphera Pharmaceuticals DCPH	2.2 K	-	-	$ 2.18 B	USA
Alexion Pharmaceuticals, Inc. ALXN	78.2	-	-	$ 40.3 B	USA
AstraZeneca PLC AZN	265	-	-	$ 96.9 B	Britain
Midatech Pharma plc MTP	162	-	-18.52 %	$ 27.3 M	Britain
Affimed N.V. AFMD	2.52 K	-	-34.95 %	$ 21.5 M	Germany
Институт стволовых клеток человека ISKJ	115	-	-	-	Russia
Celyad Oncology SA CYAD	55.8 K	-	-	$ 12.5 M	Belgium
Berkeley Lights BLI	135	-	-7.31 %	$ 87 M	USA
Celldex Therapeutics CLDX	4.06 K	$ 31.27	4.37 %	$ 2.08 B	USA
Ayala Pharmaceuticals AYLA	2.21 K	-	-	$ 7.46 M	Israel
Cyclacel Pharmaceuticals CYCCP	1.79 K	-	-4.36 %	$ 27 M	USA
Anika Therapeutics ANIK	43.4	$ 14.72	-	$ 211 M	USA
Advaxis ADXS	85.6 K	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	34.4 K	-	5.93 %	$ 314 M	Canada
Enlivex Therapeutics Ltd. ENLV	981	$ 0.67	-6.8 %	$ 30.6 M	Israel
AIkido Pharma AIKI	1.92	-	1.93 %	$ 17.4 M	USA
Esperion Therapeutics ESPR	7.93 K	$ 3.15	-	$ 655 M	USA
Albireo Pharma ALBO	1.59 K	-	-0.23 %	$ 916 M	USA